Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M124,410Revenue $M15,031Net Margin (%)30.1Z-Score19.9
Enterprise Value $M123,300EPS $1.7Operating Margin %37.7F-Score7
P/E(ttm))26.3Cash Flow Per Share $0Pre-tax Margin (%)38.9Higher ROA y-yY
Price/Book19.310-y EBITDA Growth Rate %8.8Quick Ratio1.0Cash flow > EarningsN
Price/Sales8.15-y EBITDA Growth Rate %22.3Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %6.6ROA % (ttm)35.8Higher Current Ratio y-yY
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)59.2Less Shares Outstanding y-yY
Payout Ratio %34.0Shares Outstanding M2,750ROI % (ttm)69.1Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 45.964%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 45.968%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.886
($34.84)
$ 45.9632%Add 58.71%62,194
NVORuane Cunniff 2013-06-30 Buy 0.04%$30.11 - $35.33
($33.29)
$ 45.9638%New holding, 34640 sh.34,640
NVOMario Gabelli 2013-03-31 Reduce$32.24 - $38.86
($34.93)
$ 45.9632%Reduce -60.32%1,734
NVOJohn Hussman 2012-09-30 Sold Out -0.01%$28.83 - $32.15
($30.65)
$ 45.9650%Sold Out0
NVOJohn Hussman 2012-03-31 Reduce$23.09 - $28.94
($24.82)
$ 45.9685%Reduce -40%3,000
NVOMario Gabelli 2011-12-31 Add$18.92 - $23.05
($21.5)
$ 45.96114%Add 66.87%5,590
NVOJohn Hussman 2011-09-30 Buy 0.01%$19.46 - $25.45
($22.27)
$ 45.96106%New holding, 5000 sh.5,000
NVOMario Gabelli 2011-06-30 Reduce$23.4 - $26.29
($24.91)
$ 45.9684%Reduce -21.18%3,350
NVOJohn Keeley 2011-06-30 Sold Out -0.01%$23.4 - $26.29
($24.91)
$ 45.9684%Sold Out0
NVOJohn Keeley 2010-12-31 Buy 0.01%$18.2 - $22.43
($20.77)
$ 45.96121%New holding, 2780 sh.2,780
NVOMario Gabelli 2010-09-30 Reduce$16.23 - $19.85
($17.64)
$ 45.96160%Reduce -28.77%4,420
NVOVanguard Health Care Fund 2010-09-30 Sold Out -0.19%$16.23 - $19.85
($17.64)
$ 45.96160%Sold Out0
NVOMario Gabelli 2010-06-30 Reduce$14.8 - $17.06
($15.97)
$ 45.96188%Reduce -56.26%6,205
NVOVanguard Health Care Fund 2010-06-30 Reduce-0.08%$14.8 - $17.06
($15.97)
$ 45.96188%Reduce -42.86%400,000
NVOTom Gayner 2010-03-31 Add0.31%$12.77 - $15.83
($14.23)
$ 45.96223%Add 39.04%231,500
NVOVanguard Health Care Fund 2010-03-31 Reduce-0.04%$12.77 - $15.83
($14.23)
$ 45.96223%Reduce -12.5%700,000
NVOTom Gayner 2009-12-31 Buy 0.75%$12.43 - $13.87
($13.03)
$ 45.96253%New holding, 166500 sh.166,500
NVOVanguard Health Care Fund 2008-03-31 Reduce-0.21%$11.58 - $13.52
($12.78)
$ 45.96260%Reduce -35.71%900,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVO Tom Gayner 2014-06-301,075,0000.041.4
NVO Mario Gabelli 2014-06-307,62000-0.59%
NVO Ruane Cunniff 2014-06-30160,4920.010.04-33.85%
Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

    Quarterly/Annual Reports about NVO:

      News about NVO:

      Articles On GuruFocus.com
      Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Aug 23 2014 
      GAMCO CIO Howard Ward on Reliable Consumer Stock Ideas Apr 09 2014 
      Assessing the New Boss at National Oilwell Varco Mar 31 2014 
      Amgen Inc: As Good as It Gets? Feb 20 2014 
      Shire PLC: Time to Panic? Feb 07 2014 
      Weekly 52-Week Highs Highlight: ACT, NVO, NXPI, WYNN Feb 03 2014 
      AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
      Sanofi Continues to Struggle on Its Path to Recovery Nov 23 2013 
      Renaissance Man Jim Simons - A Tale of Three Pharmaceuticals and Remarkable Gains Jul 21 2013 
      Comment for Jan 27 2013 


      More From Other Websites
      [$$] Novo's Comeback Hinges on Regulators Sep 02 2014
      Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned Aug 29 2014
      NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower Aug 28 2014
      [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions Aug 27 2014
      Novo Nordisk to Pay Fine, Tresiba in Focus Aug 19 2014
      Novo Nordisk Pays for a Weekend Delay Aug 18 2014
      Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales Aug 08 2014
      Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide Aug 07 2014
      Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats Aug 07 2014
      [$$] Novo Nordisk's Net Profit Rises Aug 07 2014
      Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View Jul 29 2014
      Novo Nordisk receives positive opinion from CHMP Jul 25 2014
      EMA recommends approval for Novo Nordisk diabetes treatment Jul 25 2014
      [video] Paying for diabetes pandemic Jul 17 2014
      3 Stocks Advancing The Drugs Industry Jul 16 2014
      Sanofi's Basal Insulin Candidate Under FDA Review Jul 08 2014
      Novo Nordisk Gets FDA Nod for NovoSeven RT Jul 08 2014
      Jazz, Novo Among Medicals Showing Healthy Action Jul 07 2014

      Add Notes, Comments or Ask Questions

      User Comments

      Gintaras58
      ReplyGintaras58 - 5 months ago
      few excellent prducts to come soon
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK